Therapeutic Apheresis Services (TAS)
NHS Blood and Transplant's (NHSBT) Therapeutic Apheresis Services' function has a long history of providing life-saving and life-enhancing therapeutic services to patients.
Therapeutic Apheresis Services (TAS) provides over 1200 patients each year with access to a portfolio of therapies using technology that exchanges, removes, or collects certain components within the blood.
TAS delivers its services from six therapeutic units that are based within NHS Trusts and which operate an outpatient model for non-acute patient procedures.
Units are located in the following NHS Trusts:
- The Christie NHS Foundation Trust
- University Hospitals Bristol NHS Foundation Trust
- Oxford University Hospitals NHS Trust
- Sheffield Teaching Hospitals NHS Foundation Trust
- Leeds Teaching Hospitals NHS Trust
- Royal Liverpool and Broadgreen University Hospitals NHS Trust
Patient Blood Management
Patient Blood Management is a multidisciplinary, evidence-based approach to optimising the care of patients who might need blood transfusion.
NHS Blood and Transplant (NHSBT) are working with the Department of Health and the National Blood Transfusion Committee to further support NHS Trusts to manage their blood use effectively. Evidence shows that there is inappropriate use of blood and blood components that can be reduced and that the current trend of annual increases in use is not sustainable.
At a one-day conference in June 2012 a panel of experts and influencers in the field considered international best practice and what can be done to ensure a Patient Blood Management approach is adopted across England and North Wales. The conference had the support of the NHS Medical Director, Professor Sir Bruce Keogh.